Skip to main content

MoneyWorks4Me

Nectar Lifesciences informs about disclosure

31 Oct 2025 Evaluate
Nectar Lifesciences has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 30, 2025 for Sanjiv Goyal & Sanjiv HUF.

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1768.00
Dr. Reddys Labs. 1340.25
Cipla 1382.00
Lupin 1996.55
Zydus Lifesciences 1239.95
View more..